Buy Aurobindo Pharma, says CA Rudramurthy BV

CA Rudramurthy BV of Vachana Investments told CNBC-TV18, "Aurobindo Pharma, for me looks like one of the best pharmaceutical stocks from a midcap sector and pharmaceutical definitely even though was not doing good, USFDA problems are all creeping in, Aurobindo will definitely stand upon it. For me, this stock has already made a small retracement of a longer trend from levels of Rs 880, it came down all the way to Rs 600. And that Rs 600, it took a strong support and now, it has already retraced 50 percent of the entire move.""Now at levels of Rs 770-780, definitely, it is a wonderful buy for me at current levels. Definitely the investors can get in to this stock somewhere closer to levels of Rs 765 and one can just keep a stoploss below Rs 760 and can look at targets of Rs 830-850 for a 3-6 months timeframe," he added.